BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25898316)

  • 1. High SEPT9_i1 protein expression is associated with high-grade prostate cancers.
    Gilad R; Meir K; Stein I; German L; Pikarsky E; Mabjeesh NJ
    PLoS One; 2015; 10(4):e0124251. PubMed ID: 25898316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging of hypoxia-inducible factor 1α and septin 9 interaction by bimolecular fluorescence complementation in live cancer cells.
    Golan M; Mabjeesh NJ
    Oncotarget; 2017 May; 8(19):31830-31841. PubMed ID: 28380438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
    Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
    Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue.
    Connolly D; Hoang HG; Adler E; Tazearslan C; Simmons N; Bernard VV; Castaldi M; Oktay MH; Montagna C
    Biol Chem; 2014 Feb; 395(2):157-67. PubMed ID: 24127542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEPT9_i1 and genomic instability: mechanistic insights and relevance to tumorigenesis.
    Peterson EA; Stanbery L; Li C; Kocak H; Makarova O; Petty EM
    Genes Chromosomes Cancer; 2011 Nov; 50(11):940-9. PubMed ID: 21910160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.
    Amir S; Golan M; Mabjeesh NJ
    Mol Cancer Res; 2010 May; 8(5):643-52. PubMed ID: 20407014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
    Golan M; Mabjeesh NJ
    Cell Cycle; 2013 Jul; 12(14):2297-308. PubMed ID: 24067372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-α7 to drive hypoxia-inducible factor (HIF)-1α nuclear translocation.
    Tazat K; Schindler S; Depping R; Mabjeesh NJ
    Cytoskeleton (Hoboken); 2019 Jan; 76(1):123-130. PubMed ID: 29742803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
    Vardi-Oknin D; Golan M; Mabjeesh NJ
    PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Septin 9_i2 is downregulated in tumors, impairs cancer cell migration and alters subnuclear actin filaments.
    Verdier-Pinard P; Salaun D; Bouguenina H; Shimada S; Pophillat M; Audebert S; Agavnian E; Coslet S; Charafe-Jauffret E; Tachibana T; Badache A
    Sci Rep; 2017 Mar; 7():44976. PubMed ID: 28338090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septin-microtubule association via a motif unique to isoform 1 of septin 9 tunes stress fibers.
    Kuzmić M; Castro Linares G; Leischner Fialová J; Iv F; Salaün D; Llewellyn A; Gomes M; Belhabib M; Liu Y; Asano K; Rodrigues M; Isnardon D; Tachibana T; Koenderink GH; Badache A; Mavrakis M; Verdier-Pinard P
    J Cell Sci; 2022 Jan; 135(1):. PubMed ID: 34854883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling of the oncogenic septin 9 reveals isoform-specific interactions in breast cancer cells.
    Devlin L; Okletey J; Perkins G; Bowen JR; Nakos K; Montagna C; Spiliotis ET
    Proteomics; 2021 Oct; 21(19):e2100155. PubMed ID: 34409731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.
    Mannan R; Bhasin TS; Manjari M; Singh G; Bhatia PK; Sharma S
    Indian J Pathol Microbiol; 2016; 59(4):489-495. PubMed ID: 27721279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression.
    Connolly D; Yang Z; Castaldi M; Simmons N; Oktay MH; Coniglio S; Fazzari MJ; Verdier-Pinard P; Montagna C
    Breast Cancer Res; 2011 Aug; 13(4):R76. PubMed ID: 21831286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
    Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
    Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
    Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.